ACM
KALA icon

ADAR1 Capital Management’s KALA BIO KALA Stock Holding History

ADAR1 Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,830
Closed -$24.5K – 311
2026
Q1 		$24.5K Hold
2,830
– – ﹤0.01% 305
2025
Q4 		$78.6K Sell
2,830
-10
-0.4% -$448 0.01% 260
2025
Q3 		$217K Sell
2,840
-157
-5% -$77.9K 0.02% 176
2025
Q2 		$713K Sell
2,997
-2,982
-50% -$582K 0.11% 99
2025
Q1 		$1.71M Buy
5,979
+1,572
+36% +$595K 0.32% 63
2024
Q4 		$1.53M Sell
4,407
-1,714
-28% -$540K 0.31% 59
2024
Q3 		$1.74M Hold
6,121
– – 0.28% 54
2024
Q2 		$2.17M Buy
+6,121
New +$2.02M 0.41% 41

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

ADAR1 Capital Management's KALA Position: Q2 2026 in Review

ADAR1 Capital Management sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 2,830 shares — an estimated $24.5K sold.

ADAR1 Capital Management first reported a position in KALA in Q2 2024 and held it in 8 quarters. The position peaked at $2.17M in Q2 2024. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • ADAR1 Capital Management reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 2,830 KALA BIO shares in Q2 2026, an estimated $24.5K.
  • ADAR1 Capital Management first reported a position in KALA BIO in Q2 2024 and held it in 8 quarters.
  • ADAR1 Capital Management's KALA BIO position peaked at $2.17M in Q2 2024.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.